Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
SDHB
REST API REST API
Homo sapiens
SDHB is differentially expressed in 259 experiments: 103 organism parts: heart, liver, ... (101 more);, 184 disease states: normal, control, ... (182 more);, 67 cell types 306 cell lines 35 compound treatments and 63 other conditions.
Synonyms SDH, SDH1
Orthologs SDHB (Gallus gallus)   Sdhb (Rattus norvegicus)   ENSCING00000006854 (Ciona intestinalis)   sdhb (Danio rerio)   SDH2 (Saccharomyces cerevisiae)   DHSB_BOVIN (Bos taurus)   Sdhb (Mus musculus)   SdhB (Drosophila melanogaster)   CG7349 (Drosophila melanogaster)   sdhb (Xenopus laevis)   Q0QEY4_CANFA (Canis familiaris)   (Compare orthologs)
Gene Ontology Term oxidoreductase activity, 3 iron, 4 sulfur cluster binding, transport, protein binding, mitochondrial inner membrane, succinate dehydrogenase (ubiquinone) activity, membrane, respiratory electron transport chain, metal ion binding, 4 iron, 4 sulfur cluster binding, aerobic respiration, mitochondrial respiratory chain complex II, electron carrier activity, iron-sulfur cluster binding, ubiquinone binding, tricarboxylic acid cycle, mitochondrion, 2 iron, 2 sulfur cluster binding, succinate metabolic process, oxidation-reduction process
InterPro Term Succ_DH/fum_Rdtase_Fe-S, Ferredoxin
UniProt Accession Q0QEY7, P21912, Q70SX8
Gene-Disease Assocation PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA, PHEOCHROMOCYTOMA, COWDEN-LIKE SYNDROME, GASTROINTESTINAL STROMAL TUMOR; GIST, PARAGANGLIOMAS 4; PGL4
Search EB-eye ENSG00000117118
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-803, E-GEOD-15765, E-GEOD-1577, E-MEXP-433, E-GEOD-3526, ... (30 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-GEOD-4525, E-GEOD-19639, E-GEOD-18005, ... (34 experiments)

Factor Value U/D Experiments
HL-60
3
E-GEOD-24147, E-GEOD-96, E-MTAB-37
MCF-7
3
E-GEOD-20081, E-GEOD-19639, E-GEOD-3529
BT474
2
E-MEXP-440, E-MTAB-62
DU145
2
E-GEOD-17482, E-GEOD-20089
MDAMB175VII
2
E-MTAB-37, E-MTAB-62
THP1
1
E-MTAB-37
300 more value(s).


Cell type

studied in E-GEOD-3920, E-GEOD-13987, E-TABM-34, E-GEOD-21909, E-GEOD-2822, ... (39 experiments)

Factor Value U/D Experiments
CD8+ T cell
2
E-AFMX-5, E-MTAB-25
stromal cell
2
E-GEOD-10797, E-MEXP-2034
721 B lymphoblast
2
E-AFMX-5, E-TABM-145
epithelial cell
1
2
E-GEOD-10797, E-MEXP-2034, E-GEOD-4483
single positive thymocyte
1
E-GEOD-1460
eosinophil
1
E-GEOD-3982
61 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-2466, E-GEOD-1577, E-MEXP-1121, E-TABM-15, ... (50 experiments)

Factor Value U/D Experiments
prostate carcinoma
3
E-MEXP-2034, E-GEOD-96, E-MTAB-62
acute promyelocytic leukemia
2
E-GEOD-96, E-GEOD-995
cervical carcinoma
2
E-MTAB-62, E-MEXP-1331
colon carcinoma
2
E-MTAB-62, E-GEOD-3726
lung adenocarcinoma
2
E-MTAB-37, E-MTAB-62
multiple myeloma
2
E-MTAB-62, E-GEOD-6691
178 more value(s).


Compound treatment

studied in E-GEOD-6907, E-GEOD-15205, E-GEOD-5824, E-TABM-868, E-GEOD-5099, ... (22 experiments)

Factor Value U/D Experiments
ethanol
2
E-MEXP-2241, E-GEOD-3113
Cxcl12
1
E-GEOD-7307
bis [(+)-tartrato] diantimonate (III) dipotassium trihydrate
1
E-GEOD-6907
5-aza-2'-deoxycytidine
2
1
E-MEXP-1269
bacterial endotoxin
1
E-GEOD-3284
control for heregulin
1
E-GEOD-6462
29 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
tunicamycin
1
E-GEOD-19519
DMSO
1
E-GEOD-19519


BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

Cellular component
studied in E-GEOD-1400

Classifier
studied in E-GEOD-3493

Clinical history
studied in E-GEOD-22097, E-TABM-234, E-GEOD-19743, E-GEOD-7967, E-GEOD-21589, ... (7 experiments)

Clinical info
studied in E-MTAB-37, E-MEXP-1251, E-GEOD-21374, E-GEOD-1563, E-GEOD-21589, ... (7 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-19743, E-GEOD-1614, E-GEOD-6236, E-GEOD-2666, E-GEOD-4667, ... (6 experiments)

Disease staging
studied in E-GEOD-89, E-GEOD-19743, E-GEOD-7788, E-GEOD-22148, E-TABM-147, ... (7 experiments)

Environmental stress
studied in E-GEOD-1643

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

family id
studied in E-GEOD-19519

Genetic modification
studied in E-MTAB-73, E-GEOD-7578, E-GEOD-17385, E-MEXP-2340, E-MEXP-563 ... (5 experiments)

Genotype
studied in E-GEOD-22056, E-GEOD-2466, E-GEOD-17476, E-GEOD-21750, E-MEXP-421, ... (11 experiments)

Gestation age
studied in E-GEOD-14334

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263, E-MEXP-1220, E-GEOD-5681, E-MEXP-2657, E-GEOD-12773, ... (12 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-GEOD-21653, E-TABM-276

Individual
studied in E-MTAB-197, E-TABM-325, E-GEOD-2466, E-GEOD-1926, E-MEXP-2069, ... (29 experiments)

Infection
studied in E-GEOD-2405, E-GEOD-12108, E-GEOD-12254, E-MEXP-561, E-GEOD-980, ... (6 experiments)

Karyotype
studied in E-GEOD-7214, E-GEOD-22056

Labeling
studied in E-LGCL-5

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-MEXP-455, E-GEOD-9171

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Molecular subtype
studied in E-GEOD-21653

Observation
studied in E-TABM-276

organ
studied in E-GEOD-24283

Organism
studied in E-AFMX-1, E-GEOD-426, E-TABM-84

Performer
studied in E-LGCL-5

Phenotype
studied in E-GEOD-19703, E-GEOD-22309, E-GEOD-21750, E-GEOD-2487

Population
studied in E-MTAB-197, E-GEOD-4922

Protocol type
studied in E-GEOD-22097, E-GEOD-21837, E-GEOD-19445, E-GEOD-19246

RNAi
studied in E-MEXP-1509, E-MEXP-101, E-GEOD-3697, E-MEXP-1857, E-MEXP-1315, ... (6 experiments)

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-MEXP-70

Sex
studied in E-GEOD-1643, E-GEOD-2466, E-GEOD-7307

Stimulation
studied in E-GEOD-20114, E-GEOD-11428

stimulus
studied in E-GEOD-22103

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

targeted_cell_type
studied in E-MEXP-70

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Test result
studied in E-GEOD-1926, E-TABM-276

Tissue
studied in E-GEOD-30573

Translocation cyclin group
studied in E-GEOD-2912

Treatment
studied in E-GEOD-22369, E-GEOD-22368, E-GEOD-16837, E-GEOD-19246, E-GEOD-12198 ... (5 experiments)

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4290

Vehicle
studied in E-GEOD-5258

Processing time: 0.468 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM